+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

Antibody Drugs: Technologies and Global Markets - Product Thumbnail Image

Antibody Drugs: Technologies and Global Markets

  • Report
  • September 2024
  • 156 Pages
  • Global
From
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 159 Pages
  • Global
From
T-Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

T-Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • September 2021
  • 102 Pages
  • Global
From
US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 - Product Thumbnail Image

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

  • Report
  • July 2023
  • 3600 Pages
  • United States
From
Combination Antibody Therapy - Global Strategic Business Report - Product Thumbnail Image

Combination Antibody Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Waldenstrom Macroglobulinemia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Waldenstrom Macroglobulinemia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 104 Pages
  • Global
From
Chronic Myelogenous Leukemia Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Chronic Myelogenous Leukemia Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 89 Pages
  • Global
From
Global T-Cell Therapy Market - Distribution by Type of Therapy, Target Indications, Target Antigens, Key Players and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Global T-Cell Therapy Market - Distribution by Type of Therapy, Target Indications, Target Antigens, Key Players and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • August 2022
  • 1180 Pages
  • Global
From
T-cell Acute Lymphoblastic Leukemia Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

T-cell Acute Lymphoblastic Leukemia Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 120 Pages
  • Global
From
CD47 Targeting Therapeutics Market by Target Disease Indication, Type of Molecule Key Players and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2035 - Product Thumbnail Image

CD47 Targeting Therapeutics Market by Target Disease Indication, Type of Molecule Key Players and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2035

  • Report
  • September 2021
  • 178 Pages
  • Global
From
TCR-based Therapies Market by Target Indications, Target Antigens, Key Players and Key Geographies, Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

TCR-based Therapies Market by Target Indications, Target Antigens, Key Players and Key Geographies, Industry Trends and Global Forecasts, 2021-2030

  • Report
  • March 2021
  • 397 Pages
  • Global
From
Immune Checkpoint Inhibitors Market by Type, Indication, Route of Administration, End-Users, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market by Type, Indication, Route of Administration, End-Users, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 188 Pages
  • Global
From
Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030 - Product Thumbnail Image

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

  • Report
  • February 2020
  • 360 Pages
  • Global
From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 734 Pages
  • Global
From
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 1079 Pages
  • Global
From
Immunotherapy Drugs Market 2024-2028 - Product Thumbnail Image

Immunotherapy Drugs Market 2024-2028

  • Report
  • November 2023
  • 163 Pages
  • Global
From
Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030 - Product Thumbnail Image

Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030

  • Report
  • July 2019
  • 800 Pages
  • Global
From
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 4115 Pages
  • Global
From
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Loading Indicator